Hepatic injury and COVID-19: pathogenic mechanisms or epiphenomena?

Rev Esp Enferm Dig. 2021 Jul;113(7):554-555. doi: 10.17235/reed.2021.7851/2021.

Abstract

Ampuero J et al. analyzed the relationship between liver injury and clinical progression of the disease in a meta-analysis of over 5,000 COVID-19 patients. The authors reported an association between increased aspartate aminotransferase (AST), alanine aminotransferase (ALT) and bilirubin levels with mortality, admission to Intensive Care and the development of complications, respectively.

Publication types

  • Letter
  • Comment

MeSH terms

  • Alanine Transaminase
  • Aspartate Aminotransferases
  • COVID-19*
  • Humans
  • Liver
  • SARS-CoV-2

Substances

  • Aspartate Aminotransferases
  • Alanine Transaminase